BiotechTube
20/20 BioLabs

20/20 BioLabs

Durham, United States· Est.
2020biolabs.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

20/20 BioLabs is a private, early-revenue diagnostics company pioneering AI-driven blood tests for early disease detection. Its core technology focuses on protein tumor markers and inflammatory biomarkers, offering a cost-effective and convenient at-home collection model. The company's lead commercial product is OneTest™ for Cancer, with a pipeline including OneTest for Longevity, positioning it in the competitive but high-growth markets of multi-cancer screening and proactive health management.

OncologyChronic Disease Prevention

Technology Platform

AI/ML-powered diagnostic platform analyzing protein biomarkers (tumor markers and inflammatory markers) from capillary blood, enabled by at-home collection devices and a CLIA/CAP lab.

Opportunities

The low-cost, at-home model opens the large, underserved market for affordable cancer screening and proactive health monitoring.
Expansion into the fast-growing longevity and wellness diagnostics sector provides a second major growth engine.
Strategic partnerships with employers, health systems, or larger diagnostics firms could accelerate market penetration.

Risk Factors

The protein-based approach faces intense competition from well-funded companies using cfDNA technology, requiring robust independent clinical validation.
Securing insurance reimbursement is a major hurdle for widespread adoption, and scaling a direct-to-consumer brand requires significant marketing investment.
The company is reliant on successful ongoing capital raises to fund growth and operations.

Competitive Landscape

In MCED, 20/20 BioLabs competes against giants like GRAIL (Guardant Health) and Exact Sciences, which offer more expensive, DNA-based tests. Its key differentiators are price and collection method. In preventive health, it faces numerous DTC lab companies (e.g., InsideTracker, Function Health) and established lab giants (Quest, LabCorp) offering wellness panels. Its AI-driven specificity and focus on actionable inflammation guidance are its competitive angles.

More companies in Diagnostics & Precision Medicine →More companies in United States →